Orion Biotechnology Completes Scientific Advice Meeting with MHRA
OTTAWA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, announced today the completion of a scientific advice meeting with the Medicines and Healthcare products Regulatory Agency (MHRA), UK, regarding the company’s innovative microbicide candidate OB-002H. This follows on from a previous Pre-IND interaction with the United States Food and Drug Administration.
Despite the increased uptake of Pre-Exposure Prophylaxis (PrEP) with oral Truvada, we are still seeing unacceptable levels of new HIV infections and it is clear that the HIV prevention field needs additional options including topical products. Designed to prevent the transmission of HIV, OB-002H gel has the potential to address an urgent and growing need for an HIV prevention product that is affordable, appealing to use, and easily integrates into the lifestyles of people at risk for HIV infection regardless of age, sex or gender.
Dr. Ian McGowan, Chief Scientific Officer of Orion Biotechnology, said, “We were very pleased to have had this dialogue with the MHRA. It confirmed that our pre-clinical program includes all the studies and data needed to complete our clinical trial application (CTA), and that our clinical study design was appropriate and met MHRA requirements. This is an important step in completing preparations for our CTA submission and bringing our novel microbicide to the clinical phase of testing which will take place in Poland. We look forward to receiving feedback from the Polish National Regulatory authority about our Phase 1 study.”
“The meeting with the MHRA was a very important step for the Company as it provided us with a clear endorsement that our preclinical and clinical programs were in line with MHRA expectations for the conduct of microbicide development. It also gives us confidence that the CTA we submit in Poland should be acceptable to the Polish National Regulatory Authority and allow us to enter the clinic with minimal delay,” commented Mark Groper, President and CEO of Orion. “Following this informative meeting with the MHRA, we can confirm that we are on track to evaluate OB-002H in a clinical trial for both men and women that should begin in Q2 2019.”
About Orion Biotechnology Canada, Ltd.
Orion Biotechnology Canada Ltd, is a privately held pharmaceutical company founded on the vision of radically improving the health of the global population through successful treatment and prevention of the most serious chronic illnesses and life-threatening diseases. Since 2011, Orion has been developing a robust pipeline of potential products based on novel formulations discovered in different parts of the world. Our close ties to diverse institutions and experts around the globe continue to stimulate the rapid discovery of promising new treatments. With operations in North America, Europe and Asia, Orion brings together innovative technologies from some of the world’s leading research institutions such as the Mintaka Research Foundation and the Center for Public Health Research at Nanjing University. Learn more at www.orionbiotechnology.com.
This press release contains forward-looking information, which reflects Orion’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Orion’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. These forward-looking statements are made as of the date of this press release and, except as expressly required by applicable law, Orion assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact: Ross MacLeod
343 Preston Street
11th Floor, Ottawa, Ontario
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Algeco Enters Into Definitive Agreement to Sell Target Lodging14.11.2018 00:59 | Pressemelding
LONDON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Algeco Investments B.V. (“Algeco Investments”, and together with its subsidiaries, “Algeco”), the leading global business services provider of modular space, secure portable storage solutions and remote workforce accommodations, today announced that certain of its subsidiaries have entered into a definitive agreement (the “Stock Purchase Agreement”) with Platinum Eagle Acquisition Corp., a publicly traded special purpose acquisition company (“PEAC”), to sell the Algeco Group’s North American remote accommodations business, Target Lodging, to Target Lodging Holdings Corp. (“Holdco”), a newly-formed subsidiary of PEAC (the “Transaction”). Simultaneously to the Target Lodging sale, TDR Capital LLP will be selling its Signor Holdings business to PEAC as well. Andrew Tyler, CEO Algeco: “We are very excited about the sale of Target Lodging to Platinum Eagle Acquisition Corp. This sale captures significant value for Algeco and allows Algeco to continu
This is a test from GlobeNewswire13.11.2018 23:54 | Pressemelding
LONDON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING – -END- CONTACT: Karen Yu Senior Director, Global Head of GlobeNewswire Media Relations Direct: +1 310 258 6917 Mobile: +1 626 389 7427 or David Didier Lislet Manager, GlobeNewswire Media Relations, EMEA Phone: +33 185 341 347
ELS Educational Services, Inc. Wins English Language School Award for Sixth Consecutive Year13.11.2018 23:20 | Pressemelding
ELS Educational Services, Inc. won the award for English Language School – USA at the UED Agency Awards of Turkey. This is the sixth consecutive year ELS has won the award. Princeton, New Jersey, Nov. 13, 2018 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE ELS Educational Services, Inc. won the award for English Language School – USA at the UED Agency Awards of Turkey. This is the sixth consecutive year ELS has won the award. The UED Agency Awards is the first competition of its kind that recognizes excellence among language schools and service providers in Turkey. Institutions are nominated then voted on by UED Member Agencies, who are the leaders of the international education consultancy sector in Turkey. “The ELS brand is stronger than ever in Turkey,” said Osman Akyuz, Director of Recruitment and Agent Support in Turkey. “We provide the best academic English in great locations and we have the most experienced instructors.” ELS was presented the award at a banquet at the Divan Otel / Ta
Doc re. GE Files Form 8-K13.11.2018 17:30 | Pressemelding
FAIRFIELD, Conn., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Company General Electric Company ISIN US3696041033 Symbol London: GEC | Paris: GNE Headline Doc re: GE files Form 8-k November 13, 2018 On November 13, 2018, General Electric Company (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"), which has been submitted to RNS. It is also available on the SEC's website at http://www.sec.gov and on the Company's website at https://www.ge.com/investor-relations/events-reports. http://www.rns-pdf.londonstockexchange.com/rns/2365H_1-2018-11-13.pdf CONTACT: GE Jennifer Erickson +001 646 682 5620 firstname.lastname@example.org This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visi
CloudGenix Named a Finalist in the 2018 CRN® Tech Innovator Awards13.11.2018 17:00 | Pressemelding
Company’s AppFabric Recognized in the 2018 Enterprise Networking Category SAN JOSE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CloudGenix announced today that CRN , ® a brand of The Channel Company, has been recognized as a finalist in the 2018 CRN Tech Innovator Awards. These annual awards honor standout hardware, software, and services that are moving the IT industry forward. In compiling the 2018 Tech Innovator Award list, CRN editors evaluated 300 products across 34 technology categories using several criteria, including technological advancements, uniqueness of features and potential to help solution providers solve end users' IT challenges. CloudGenix’s AppFabric took top honors in the Enterprise Networking category. CloudGenix AppFabric is a revolutionary software-defined wide area networking (SD-WAN) platform that allows businesses to integrate cloud and SaaS applications, create a secure application-defined fabric across any WAN transport, reduce operational cost and complexity
Atico Reports Reserves of 119 Million Pounds of Copper at the El Roble Mine13.11.2018 15:51 | Pressemelding
VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is pleased to announce the release of an updated NI 43-101 mineral resource and reserve estimate for the El Roble Mine located in Colombia. El Roble is currently in production at a rate of 850tpd and production guidance for the year is 20 million pounds of copper along with 9,850 ounces of gold in 2018. For the first three quarters of 2018, El Roble has produced 16 million pounds of copper and 8,400 ounces of gold or over 80% and 85% of annual forecast production for copper and gold respectively. “Our infill and mine vicinity exploration drilling at El Roble mine has been successful in replenishing mined resources since 2013. The maiden resource study at El Roble mine of 1.5 million tonnes of inferred resource has grown to 1.8 million tonnes of measured and indicated resources, while also having mined over 1 million tonnes of high-grade ore during
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom